HDL-c levels were lower in FH patients compared with controls (P < 0.001) and there were no differences between FH subjects with null and defective LDL-r mutations (49.1 ± 11.8 and 51.2 ± 14.3 mg/dl, respectively, P = 0.208). This evidence concerns the gene LDLR and familial hyperaldosteronism.